9 CFR Topic
Antibody Products
November 6, 2020
§
113.450
General requirements for antibody products
§
113.451
Tetanus Antitoxin
§
113.452
Erysipelothrix Rhusiopathiae Antibody
§
113.453
[Reserved]
§
113.454
Clostridium Perfringens Type C Antitoxin
§
113.455
Clostridium Perfringens Type D Antitoxin
§
§113.456-113.498
[Reserved]
§
113.499
Products for treatment of failure of passive transfer